EpimAb nabs Bin Peng from NIBR; Jeffrey Chodakewitz exits Vertex; Christiana Stamoulis is president at Unum
→ Christiana Stamoulis is getting busier at Unum Therapeutics as she adds the role of president to her CFO and head of corporate development duties. She will now be responsible for many of the immunotherapy company’s functions, including corporate strategy, legal, investor relations and communications. A former investment banker and Vertex exec, Stamoulis was credited for heading Unum’s $65 million series B and its partnership with Seattle Genetics.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.